Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Hans-Erich Boenigk"'
Publikováno v:
Seizure. 10(2):120-124
The efficacy and safety of methsuximide (MSM) was evaluated in children with intractable epilepsies in a prospective uncontrolled study. MSM was added to the therapeutic regimen of 112 children with intractable epilepsy under inpatient conditions, al
Publikováno v:
Kindheit und Entwicklung. 9:50-61
Zusammenfassung. Mit Hilfe einer adaptierten Version der Parenting Stress Index ( Abidin, 1990) wurde die Stressbelastung von 86 Müttern mit anfallskranken Kindern im Alter von 1 bis 12 Jahren erfaßt. Die mütterliche Belastung war unabhängig von
Publikováno v:
Epilepsy Research. 38:27-32
Purpose : To evaluate the efficacy and safety of gabapentin (GBP) in partial epilepsy in children. Methods : We performed a prospective open label add-on study in 52 children and adolescents (age 1.8–17.5 years, mean 11.1 years) with refractory par
Publikováno v:
Journal of Epilepsy. 11:355-360
Oxcarbazepine (OCBZ) is one of the new antiepileptic drugs (AEDs) currently available in several countries. While it is rated as having fewer side effects than carbamazepine (CBZ) there has been a paucity of studies in children. We retrospectively re
Publikováno v:
Epilepsy Research. 26:345-349
In the therapy of absence epilepsies, a combination of ethosuximide (ESM) and valproic acid (VPA) is sometimes necessary for a successful seizure control. Previous studies of the interaction between ESM and VPA revealed contradictory results. We inve
Autor:
Elisabeth Korn-Merker, Ulrich Bettendorf, Peter Borusiak, Hans Erich Boenigk, Michael Karenfort
Publikováno v:
Brain and Development. 22:243-245
We report on an 18-month-old girl with a seizure frequency of five/day, receiving an antiepileptic polytherapy consisting of primidone, clonazepam and phenytoin. Following discontinuation of clonazepam and primidone, the patient has been seizure-free
Publikováno v:
Epilepsy research. 30(3)
We report the case of a 12-year-old girl with severe clinically relevant hyponatremia (118 mmol/l) and hypochloremia (81 mmol/l) during treatment with oxcarbazepine (OCBZ). The adverse effects were rapidly reversible after discontinuation of OCBZ and
Publikováno v:
Epilepsia. 30(4)
Frequent unwanted side effects and development of tolerance are the main disadvantages of clonazepam (CZP) in long-term treatment of epileptic patients. A review of the literature shows that CZP tolerance more often appears in severe forms of childho